Atlas Trials

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Clinical trial NCT00962637 · COMPLETED

Trial details

NCT number
NCT00962637
Sponsor
Repros Therapeutics Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary Hypogonadism
Start date
2006-03-01
Primary completion
2007-05-01
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.